This page shows the latest compulsory licensing news and features for those working in and with pharma, biotech and healthcare.
Proposal to introduce compulsory licensing faces industry criticism. Labour Party leader Jeremy Corbyn has announced plans to “take on pharmaceutical companies” in his speech at the Labour Party Conference in Brighton. . ... Industry response. The
In April, the EMA published a paper about added therapeutic benefits and drug licensing.it is now engaging with affordability arguments, so it can’t bury its head in the sand ... In 2019, we’ve seen government ministers in the House of Commons
These would include a compulsory licensing approach called Crown Use licensing or large scale clinical trials sponsored by the government. ... Despite momentum growing behind the call for compulsory licensing, campaigners know that the process would
compulsory licensing) crown use licence, launch a large scale clinical trial and provide direct support for individuals using the buyers’ club.
The group wants the government to use its compulsory licensing laws, called Crown Use licence to bypass Vertex’s UK patents and procure these cheaper copies for use on the NHS.
This has led to the creation of Just Treatment, a new patient action group which is advocating the compulsory licensing of Vertex to break the deadlock, so-called Crown use licensing.
More from news
Approximately 1 fully matching, plus 21 partially matching documents found.
Just Treatment is also urging the UK government to override Vertex’s patent via compulsory licensing or Crown Use Licence.
It has called for a Crown Use compulsory licensing of Orkambi, but this always looked like an outside bet. ... It urges the government to use Crown use compulsory licensing to gain access to cheaper versions of Orkambi.
UK government to issue a compulsory licensing of Orkambi. ... For example in Germany, from the time of European licensing, adults and children of 12 and over were able to access Orkambi if they had the right mutations.”.
Some markets have introduced charges for access to state healthcare premises or compulsory licensing, and some HCOs are now seeking direct support either as financial donations or as medical education, patient
However, China also passed the “Measures for the Compulsory Licensing of Patent Implementation” law in May 2012. ... There are two ways of interpreting recent trends in compulsory licensing and IP loss.
More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.
imc provides healthcare communication and medical affairs support to over 50 pharmaceutical, biotech, vaccine, device, and diagnostic companies globally, including...